Literature DB >> 16036132

A novel mechanism for the modulation of the Ras-effector interaction by small molecules.

Michael Spoerner1, Thorsten Graf, Burkhard König, Hans Robert Kalbitzer.   

Abstract

When proteins require different conformations for their biological function, all these functional states have to coexist simultaneously in solution. However, the corresponding Gibbs free energy differences are usually rather high and thus the conformation with lowest energy predominates in solution whereas the populations of the states with higher energy (excited states) are very small. A stabilization of these excited states can be used as a novel principle to influence the activity of proteins by small molecules. For a proof of this principle, we selected the Ras protein that was shown by (31)P NMR spectroscopy to exist in solution in at least two different conformational states in its GTP form. One of these states shows a drastically reduced affinity to effectors. With Zn(2+)-cyclen we found a small molecule which selectively stabilizes the weak-binding state. It may serve as lead compound for the development of a new type of Ras-inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036132     DOI: 10.1016/j.bbrc.2005.06.144

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  High pressure 31P NMR spectroscopy on guanine nucleotides.

Authors:  Michael Spoerner; Matthias Karl; Pedro Lopes; Marcus Hoering; Karoline Loeffel; Andrea Nuehs; Joseph Adelsberger; Werner Kremer; Hans Robert Kalbitzer
Journal:  J Biomol NMR       Date:  2016-12-23       Impact factor: 2.835

Review 3.  Small-molecule modulation of Ras signaling.

Authors:  Jochen Spiegel; Philipp M Cromm; Gunther Zimmermann; Tom N Grossmann; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2014-06-15       Impact factor: 15.040

4.  Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis.

Authors:  Michael Spoerner; Constantin Hozsa; Johann A Poetzl; Kerstin Reiss; Petra Ganser; Matthias Geyer; Hans Robert Kalbitzer
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

Review 5.  High-field solution NMR spectroscopy as a tool for assessing protein interactions with small molecule ligands.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

Review 6.  Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Authors:  Imran Khan; J Matthew Rhett; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-10-31       Impact factor: 4.739

Review 7.  Pharmacological targeting of RAS: Recent success with direct inhibitors.

Authors:  John P O'Bryan
Journal:  Pharmacol Res       Date:  2018-10-23       Impact factor: 7.658

8.  Novel allosteric sites on Ras for lead generation.

Authors:  Barry J Grant; Suryani Lukman; Harrison J Hocker; Jaqueline Sayyah; Joan Heller Brown; J Andrew McCammon; Alemayehu A Gorfe
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

9.  Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins.

Authors:  Alemayehu A Gorfe; Barry J Grant; J Andrew McCammon
Journal:  Structure       Date:  2008-06       Impact factor: 5.006

10.  Molecular Mechanism for Conformational Dynamics of Ras·GTP Elucidated from In-Situ Structural Transition in Crystal.

Authors:  Shigeyuki Matsumoto; Nao Miyano; Seiki Baba; Jingling Liao; Takashi Kawamura; Chiemi Tsuda; Azusa Takeda; Masaki Yamamoto; Takashi Kumasaka; Tohru Kataoka; Fumi Shima
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.